CAR T-Cell Therapy in DLBCL: Centers of Excellence – OncLive
OncLive |
CAR T-Cell Therapy in DLBCL: Centers of Excellence
OncLive The reason I say that is because chemotherapy tends to deplete normal T cells, and we need normal T cells to generate CAR T cells. If a patient comes after 4, 5, or 6 prior therapies and doesn't have any peripheral blood lymphocytes to collect, it may … |
